Ciprofloxacin injection bayer
Resistance During or following a course of treatment with ciprofloxacin bacteria that demonstrate resistance to ciprofloxacin may be isolated, with or without a clinically apparent superinfection.
Co-administration of ciprofloxacin and tizanidine is contra-indicated. Comparison of the pharmacokinetic parameters for a twice a day and three times a day intravenous dose regimen indicated no evidence of drug accumulation for ciprofloxacin and its metabolites. Concurrent administration of ciprofloxacin and theophylline can cause an undesirable increase in serum theophylline concentration.
Glucosephosphate dehydrogenase deficiency Haemolytic reactions have been reported with ciprofloxacin in patients with glucosephosphate dehydrogenase deficiency. Non-clinical data reveal no special hazards for humans based on conventional studies of single dose toxicity, repeated dose toxicity, carcinogenic potential, or toxicity to reproduction. In severe cases or if the patient is unable to take tablets e.
Genital tract infections Epididymo-orchitis and pelvic inflammatory diseases may be caused by fluoroquinolone-resistant Neisseria gonorrhoeae isolates.
Date of revision of the text. Patients with renal and hepatic impairment Recommended starting and maintenance doses for patients with impaired renal function: Haemophilus influenzae and Moraxella catarrhalis.
Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity. Metabolism and Nutrition Disorders. Find out more here.
Marketing authorisation holder 8. Ciprofloxacin has been shown to cause photosensitivity reactions. Ciprofloxacin may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection. Increased serum tizanidine concentration is associated with a potentiated hypotensive and sedative effect.
Penetration of the outer ring may result in damage to the vial stopper. Qualitative and quantitative composition 3. The in-vitro activity of ciprofloxacin against Mycobacterium tuberculosis might give false negative bacteriological test results in specimens from patients currently taking ciprofloxacin. For children, the infusion duration is 60 minutes.
Products Affected - Description
Ciprofloxacin should be used in combination with other antimicrobial agents depending on the results of the microbiological documentation. The duration of treatment depends on the severity of the illness and on the clinical and bacteriological course.
Ciprofloxacin may also be used to treat severe infections in children and adolescents when this is considered to be necessary.
Zolpidem Co-administration of ciprofloxacin may increase blood levels of zolpidem, concurrent use is not recommended. Theophylline Concurrent administration of ciprofloxacin and theophylline can cause an undesirable increase in serum theophylline concentration.
Not all pack sizes may be marketed. Subscribe to receive email notifications whenever new articles are published.